Ishaque Hameed

Dr. Ishaque Hameed

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
EKElizabeth A. Kobe
Elizabeth A. Kobe
TMTodd McVeigh
Todd McVeigh
IHIshaque Hameed
Ishaque Hameed
MFMarat Fudim
Marat Fudim
Heart failure (HF) is a significant clinical and financial burden worldwide. Remote monitoring (RM) devices capable of identifying early physiologic changes in decompensation have the potential to reduce the HF burden. However, few trials have discussed at length the practical aspects of implementing RM in real-world clinical practice. The present paper reviews current RM devices and clinical trials, focusing on patient populations, outcomes, data collection, storage, and management, and describes the implementation of an RM device in clinical practice, providing a pragmatic and adaptable framework.

21 June 2018 in Cureus
Verified
Journal Article
Open access
PDF file
ZMZainab Mohsin
Zainab Mohsin
AAArifa A Asghar
Arifa A Asghar
AFArisha Faiq
Arisha Faiq
IKIlma Khalid
Ilma Khalid
IUIbtehaj Ul-Haque
Ibtehaj Ul-Haque
MSMarzia Safri
Marzia Safri
Rheumatic diseases are referred to as conditions affecting joints, muscles, ligaments, tendons, and bones. According to a report by World Health Organization, rheumatic and musculoskeletal diseases were labeled as the second most reported cause of disability around the globe. The purpose of this study was to estimate the prevalence of rheumatic diseases in a tertiary care hospital of Karachi; additionally, associations with age groups, gender and comorbidities were obtained as well. A cross-sectional study was conducted at the Orthopedic Out Patient Department (OPD) of Dr. Ruth KM Pfau Civil Hospital, Karachi over a span of three months in 2018 (February till May). All 346 patients were follow-up diagnosed cases in the age range of 11-90 years, divided into groups of adolescents, young adults, adults, and older adults. The subjects were questioned about their symptoms, duration of illness, presence of comorbidities, genetic background and the therapy they are undergoing along with compliance. Simple statistical analysis of frequency was done, whereas chi-square test was applied to study associations with gender, age groups, and comorbidities. During the study period, a total of 2000 patients visited the orthopedic OPD, 346 of which were diagnosed cases of rheumatic diseases, yielding a prevalence of 17.3%. The mean age of rheumatic patients who partook in the study was 46.15 ± 15.49 (Range: 12 – 84). Osteoarthritis was recorded as the most prevalent condition, followed by non-specific low back pain and rheumatoid arthritis. Osteoarthritis was statistically significant in young adults, adults, and older adults, while non-specific low back pain had significant associations with gender, young adults, and adults. Diabetes was significantly associated with osteoarthritis, non-specific low back pain, shoulder pain syndrome and psoriatic arthritis, while hypertension significantly co-existed with systemic lupus erthematosus. Rheumatic diseases constitute a major disease burden in almost all of the age groups, especially in young patients (18-40 years) within our setup.

19 September 2023 in Future Science OA
Verified
Journal Article
Open access
AMAreeba Memon
Areeba Memon
MLMuhammad Omar Larik
Muhammad Omar Larik
ZKZoha Khan
Zoha Khan
MUMaryam Urooj
Maryam Urooj
AIAreeka Irfan
Areeka Irfan
IHIshaque Hameed
Ishaque Hameed
Aim: This meta-analysis was performed to assess the efficacy and safety of mavacamten in patients with hypertrophic cardiomyopathy. Methods & materials: A search was conducted using PubMed, Cochran... Plain language summary Mavacamten is a recently introduced medication that relaxes the heart muscle and is indicated for patients with hypertrophic cardiomyopathy (a disease in which parts of the h... Tweetable abstract The efficacy and safety of mavacamten, a novel drug, was assessed in patients of hypertrophic cardiomyopathy. It was noted that mavacamten significantly improved NYHA class, KCCQ... Graphical abstract

13 February 2024 in Steroids
Verified
Journal Article
Closed access
LCLuis A. Diaz Caballero
Luis A. Diaz Caballero
AAAshnah Aijaz
Ashnah Aijaz
NPNeha Saleem Paryani
Neha Saleem Paryani
SMSamar Mahmood
Samar Mahmood
MSMadiha Salman
Madiha Salman
IHIshaque Hameed
Ishaque Hameed

12 June 2023 in EXCLI Journal
Verified
Journal Article
Open access
SMSamar Mahmood
Samar Mahmood
MKMohammad Omer Khan
Mohammad Omer Khan
IHIshaque Hameed
Ishaque Hameed

5 October 2024 in The American Journal of Cardiology
Verified
Journal Article
Closed access
IHIshaque Hameed
Ishaque Hameed
KNKhushboo Nusrat
Khushboo Nusrat
AJAdeena Jamil
Adeena Jamil
KFKaneez Fatima
Kaneez Fatima
AMAbdul Mannan Khan Minhas
Abdul Mannan Khan Minhas
Muhammad Shahzeb KhanMuhammad Shahzeb Khan
Muhammad Shahzeb Khan